Filing Details

Accession Number:
0001661539-23-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-22 17:32:52
Reporting Period:
2023-12-20
Accepted Time:
2023-12-22 17:32:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819790 Tarsus Pharmaceuticals Inc. TARS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661539 M. Jose Trevejo 15540 Laguna Canyon Road
Suite 160
Irvine CA 92618
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-20 2,252 $20.00 2,251 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2023.